Multimodality treatment in immunocompromised patients with severe COVID‐19: the role of IL‐6 inhibitor, intravenous immunoglobulin, and haemoperfusion

by Nophol Leelayuwatanakul, Napplika Kongpolprom, Thitiwat Sriprasart, Vorakamol Phoophiboon, Vorawut Thanthitaweewat, Sarita Thawanaphong, Worawan Sirichana, Naricha Chirakalwasan, Kamon Kawkitinarong, Chanchai Sittipunt, Opass Putcharoen, Leilani Paitoonpong, Gompol Suwanpimolkul, Watsamon Jantarabenjakul, Nattachai Srisawat, Monvasi Pachinburavan
Published 2021-04-01